Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Gamma-hydroxybutyrate associated with dependence liability

March 4, 1997

Sustained-release methylphenidate for HIV-associated cognitive impairment

March 4, 1997

Gliatech receives grant for histamine H3 receptor antagonists

March 3, 1997

Novel polyamines fromTeva

March 3, 1997

NeoTherapeutics seeks approval for trials on neurological drug

Feb. 28, 1997

MS&D describes nonpeptide tachykinin antagonists

Feb. 28, 1997

Sigma-receptor antagonists disclosed by Taisho

Feb. 28, 1997

Taiho discloses anxiolytics

Feb. 28, 1997

Riluzole now available in France

Feb. 27, 1997

Glaxo Wellcome evaluates ondansetron alone and in combination for emesis

Feb. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...